Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms
Jack F. Chovanec, Ilker Tunc, Jason Hughes et al. · Blood Advances · 2022
Serum tryptase is a biomarker used to aid in the identification of certain myeloid neoplasms, most notably systemic mastocytosis, where basal serum tryptase (BST) levels >20 ng/mL are a minor criterion for diagnosis. Although clonal myeloid neoplasms are rare, the common cause for elevated BST levels is the genetic trait hereditary α-tryptasemia (HαT) caused by increased germline TPSAB1 copy number. To date, the precise structural variation and mechanism(s) underlying elevated BST in HαT and the general clinical utility of tryptase genotyping, remain undefined. Through cloning, long-read sequencing, and assembling of the human tryptase locus from an individual with HαT, and validating our findings in vitro and in silico, we demonstrate that BST elevations arise from overexpression of replicated TPSAB1 loci encoding canonical α-tryptase protein owing to coinheritance of a linked overactive promoter element. Modeling BST levels based on TPSAB1 replication number, we generate new individualized clinical reference values for the upper limit of normal. Using this personalized laboratory medicine approach, we demonstrate the clinical utility of tryptase genotyping, finding that in the absence of HαT, BST levels >11.4 ng/mL frequently identify indolent clonal mast cell disease. Moreover, substantial BST elevations (eg, >100 ng/mL), which would ordinarily prompt bone marrow biopsy, can result from TPSAB1 replications alone and thus be within normal limits for certain individuals with HαT.
Cited by 60 works. doi:10.1182/bloodadvances.2022007936
Authors
- Jack F. Chovanec
- Ilker Tunc
- Jason Hughes
- Joseph Halstead
- Allyson Mateja
- Yihui Liu
- Michael P. O’Connell
- Ji-Won Kim
- Young Hwan Park
- Qinlu Wang
- Quang Trong Le
- Mehdi Pirooznia
- Neil N. Trivedi
- Yun Bai
- Yuzhi Yin
- Amy P. Hsu
- Joshua J. McElwee
- Sheryce Lassiter
- Celeste M. Nelson
- Judy Bandoh
References
- Trimmomatic: a flexible trimmer for Illumina sequence data
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- The Ensembl Variant Effect Predictor
- Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and Mastocytosis
- Diagnostic criteria and classification of mastocytosis: a consensus proposal
- Strelka2: fast and accurate calling of germline and somatic variants
- Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis
- SAMBLASTER : fast duplicate marking and structural variant read extraction
- VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
- Demonstration That Human Mast Cells Arise From a Progenitor Cell Population That Is CD34+, c-kit+, and Expresses Aminopeptidase N (CD13)